ConductScience.org, home

Trial · NCT00229658

Results by group24

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Incidence of Patient-Ascertained Severe Hypoglycemia (PASH) During the Adjustment PeriodType 1 Diabetes4.8Incidence (%)
Incidence of Patient-Ascertained Severe Hypoglycemia (PASH) During the Adjustment PeriodType 2 Diabetes2.8Incidence (%)
Annual Event Rate of Patient-Ascertained Severe Hypoglycemia (PASH) During the Adjustment PeriodType 1 Diabetes0.3255Events per patient year
Annual Event Rate of Patient-Ascertained Severe Hypoglycemia (PASH) During the Adjustment PeriodType 2 Diabetes0.1941Events per patient year
The Incidence of Patient-Ascertained Severe Hypoglycemia (PASH) During the Steady State PeriodType 1 Diabetes1.8Incidence (%)
The Incidence of Patient-Ascertained Severe Hypoglycemia (PASH) During the Steady State PeriodType 2 Diabetes0.3Incidence (%)
The Annual Event Rate of Patient-Ascertained Severe Hypoglycemia (PASH) During the Steady State PeriodType 1 Diabetes0.0844Events per patient year
The Annual Event Rate of Patient-Ascertained Severe Hypoglycemia (PASH) During the Steady State PeriodType 2 Diabetes0.0248Events per patient year
Incidence of Medically Assisted Severe Hypoglycemia (MASH) During the Adjustment PeriodType 1 Diabetes1.8Incidence (%)
Incidence of Medically Assisted Severe Hypoglycemia (MASH) During the Adjustment PeriodType 2 Diabetes0.4Incidence (%)
The Annual Event Rate of Medically Assisted Severe Hypoglycemia (MASH) During the Adjustment PeriodType 1 Diabetes0.0996Events per patient year
The Annual Event Rate of Medically Assisted Severe Hypoglycemia (MASH) During the Adjustment PeriodType 2 Diabetes0.0185Events per patient year
Incidence of Medically Assisted Severe Hypoglycemia (MASH) During the Steady State PeriodType 1 Diabetes0.8Incidence (%)
Incidence of Medically Assisted Severe Hypoglycemia (MASH) During the Steady State PeriodType 2 Diabetes0.3Incidence (%)
Annual Event Rate of Medically Assisted Severe Hypoglycemia (MASH) During the Steady State PeriodType 1 Diabetes0.0375Events per patient year
Annual Event Rate of Medically Assisted Severe Hypoglycemia (MASH) During the Steady State PeriodType 2 Diabetes0.0124Events per patient year
Change in HbA1c From Baseline at Month 3Type 1 Diabetes-0.12Standard Error 0.037percent
Change in HbA1c From Baseline at Month 3Type 2 Diabetes-0.33Standard Error 0.056percent
Change in HbA1c From Baseline at Month 6Type 1 Diabetes-0.26Standard Error 0.046percent
Change in HbA1c From Baseline at Month 6Type 2 Diabetes-0.44Standard Error 0.071percent

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00229658/results